Eastman Chemical CO Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Adrian James Holt, SVP and Chief HR Officer of Eastman Chemical Company, reported transactions involving restricted stock units and common stock.
NYSE
Director Humberto P. Alfonso of Eastman Chemical Co. (EMN) has reported transactions related to phantom stock units and deferred compensation.
NYSE
Brett D. Begemann, a Director at Eastman Chemical Co., reported the acquisition of unvested phantom stock units valued at $73.69 each, totaling 1,628 units, under the Directors' Deferred Compensation Plan.
NYSE
Kim Ann Mink, a Director at Eastman Chemical Co., reported transactions involving phantom stock units and common stock.
NYSE
Director Donald W. Slager acquired 1,628 shares of Eastman Chemical Company common stock through a restricted stock award.
NYSE
Julie Fasone, a Director at Eastman Chemical Co., acquired 1,628 restricted shares on May 7, 2026, as part of her annual Restricted Stock Award.
NYSE
Renee J. Hornbaker, a Director at Eastman Chemical Co., acquired 1,628 restricted shares on May 7, 2026, as part of her annual award.
NYSE
Director James J. O'Brien of Eastman Chemical Co. acquired 1,628 restricted shares as part of his annual award.
NYSE
Damon J. Audia, a Director at Eastman Chemical Co., reported transactions involving phantom stock units under the Directors' Deferred Compensation Plan.
NYSE
Damon J. Audia, a Director at Eastman Chemical Co., acquired phantom stock units under the company's deferred compensation plan.
NYSE
Eric L. Butler, a Director at Eastman Chemical Co., reported transactions involving phantom stock units on April 8, 2026.
NYSE
Brett D. Begemann, a Director at Eastman Chemical Co., reported transactions involving phantom stock units on April 8, 2026.
NYSE
Linnie M. Haynesworth, a Director at Eastman Chemical Co., reported transactions involving phantom stock units under the company's deferred compensation plan.
NYSE
James J. O'Brien, a Director at Eastman Chemical Co., reported transactions involving phantom stock units, indicating a shift in beneficial ownership.
NYSE
Director Humberto P. Alfonso of Eastman Chemical Co. (EMN) has reported transactions related to phantom stock units, indicating changes in beneficial ownership.
NYSE
Julie Fasone, a Director at Eastman Chemical Co., reported transactions related to phantom stock units and common stock.
NYSE
Donald W. Slager, a Director at Eastman Chemical Co., reported transactions related to phantom stock units and common stock.
NYSE
Renee J. Hornbaker, a Director at Eastman Chemical Co., acquired phantom stock units through a deferred compensation plan and automatic retainer fee deferrals.
NYSE
Kim Ann Mink, a Director at Eastman Chemical Co., reported transactions involving phantom stock units on April 8, 2026.
NYSE
Eastman Chemical's SVP and Chief HR Officer, Adrian James Holt, received grants of employee stock options and restricted stock units.
NYSE
Eastman Chemical's Controller and CAO, Michelle Renee Stewart, received grants of stock options and restricted stock units.
NYSE
Julie A. McAlindon, SVP at Eastman Chemical Co., received grants of 24,364 stock options and 3,352 restricted stock units.
NYSE
Eastman Chemical CEO Mark J. Costa received significant equity awards, including stock options and restricted stock units, on February 24, 2026.
NYSE
Eastman Chemical's EVP, Brian Travis Smith, received new equity awards, including 53,157 employee stock options and 7,313 restricted stock units.
NYSE
Eastman Chemical's SVP and Chief Manufacturing Officer, Michelle H. Caveness, received significant equity awards including stock options and restricted stock units.
NYSE
Eastman Chemical's SVP, CLO & Corporate Secretary, Bosede Ikeolu Gbadegesin, received new employee stock options and restricted stock units on February 24, 2026.
NYSE
Eastman Chemical's EVP & CCO, Brad A. Lich, was granted 63,123 employee stock options and 8,684 restricted stock units on February 24, 2026.
NYSE
Eastman Chemical Co.'s EVP and CFO, William Thomas McLain Jr., acquired 59,801 employee stock options and 8,227 restricted stock units.
NYSE
Eastman Chemical's EVP & CCO, Brad A. Lich, reported the future acquisition of 18,861 common shares as performance awards for the 2023-2025 period.
NYSE
Eastman Chemical's EVP and CFO, William Thomas McLain Jr., acquired 15,883 shares of common stock through the vesting of performance shares.